Killer bees prompt response by Alabama officials as invasive swarms spotted across U.S.
Officials said the swarm was humanely euthanized to protect the state's honeybee populations, which, University of Georgia researchers note, can be threatened by this more aggressive bee subspecies.
Killer bees, also called Africanized honeybees, are a notoriously dangerous breed known for their defensiveness, according to the Smithsonian Institution. Unlike most bees typically seen in the U.S., which are technically European honeybees, these killer bees became feared after attacking humans and animals in relatively large numbers. The Smithsonian writes in a description of killer bees on its website that the insects "have killed some 1,000 humans" since their introduction to the Americas in 1956, "with victims receiving ten times as many stings than from the European strain."
In Alabama, the agricultural department said traps were set across a five-mile stretch of land near the site in Barbour County where beekeepers spotted the swarm. The department has also taken steps to establish targeted monitoring procedures in the area, to assess whether additional swarms are present. Officials said that was "a precautionary response," to protect pollinating honeybees as well as beekeepers.
"There is no reason for public concern at this time, but we are treating this situation seriously," said Rick Pate, the commissioner of the agricultural department, in a statement. "Our team is actively collaborating with local beekeepers and entomology experts to ensure swift detection and appropriate response. Protecting both the health of our communities and Alabama's honeybee populations is our top priority."
The department warned members of the public to avoid provoking any bee population suspected to contain killer bees, as they "may respond in greater numbers when disturbed" and "pursue perceived threats farther than European honeybees," potentially following them for up to a mile. In comparison, European honeybees have been known to stalk victims of an attack for up to a quarter of a mile.
Alabama's discovery has followed a spate of killer bee sightings across the country. In the last three months alone, swarms in Texas attacked and killed one man, and led to three others being hospitalized after disturbing a colony, CBS News Miami reported. According to the news site AZ Family, a swarm chased a group of hikers for about a mile near the end of a trail in a Phoenix suburb, and each hiker required medical attention as a result.
Killer bees have been spotted in 13 U.S. states: Alabama, Arizona, Arkansas, California, Florida, Georgia, Louisiana, Mississippi, Nevada, New Mexico, Oklahoma, Texas and Utah. South Florida has the highest number of them compared with any other state, according to CBS News Miami.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
New Research Suggests Intelligence Can Be Predicted as Early as 7 Months Old
Fact checked by Sarah ScottA new study found that some kids may show signs of intelligence as babies Experts say parents shouldn't let the study worry them—intelligence also depends on environment and parental involvement Intelligence is more than just IQ, and there are ways for parents to cultivate intelligence throughout their child's lifeNew parents are notorious for looking for early signs of their infant's intelligence—a babbled first word, waving or blowing kisses, a spark of recognition when they see a familiar face. Most of the time it's just an attempt to prove their baby is just as special as their parents know they are—but it might actually be possible to predict a person's adult IQ in infancy? A new study from the University of Colorado Boulder suggests your baby will show signs of intelligence just as early as new parents are convinced they can. In fact, researchers found that it may be possible to predict how well a person will perform on a cognitive test in their 30s as early as 7 months old. So, how exactly can a baby's brain reveal its future potential? To find out, University of Colorado Boulder researchers recruited 500 families with twins (both fraternal and identical). They followed participants at 7 and 9 months, then at age 1, and every year until age 17, continuing every five years into their 30s. Analyzing the decades of data collected from their participants, the goal was to better understand how genes and environment interact to shape a child's development. By studying twins, researchers could determine the distinct roles that genes and shared environment play. Since identical twins share 100% of their genes while fraternal twins share only about 50% (like regular siblings), comparing their IQ similarities allowed researchers to infer how much of cognitive ability is due to genetics versus shared environmental factors. Daniel Gustavson, PhD, an assistant research professor at the University of Colorado Boulder and lead author on the study, says a shared environment includes 'all the aspects of their home, neighborhood, school environments.' The study found that early on, the environment (before age three) can have a measurable and lasting impact on a person's cognitive ability later in life, accounting for around 10% of individual differences in IQ, Dr. Gustavson notes. To test infant cognition, researchers used seven measures, including the 'novelty preference' task that assessed how long infants spend looking at a new toy versus a familiar one, vocalizations (babbling sounds made by the infant), visual expectation (tracking an object), tester ratings (attentiveness, activity, mood), and the Bayley Scales of Infant and Toddler Development. While these specific infant tests (at seven to nine months) predicted only a small percentage of an adult's IQ, the study found that by age three, the yearly follow-ups could predict 20% of what Dr. Gustavson calls 'across-person differences' in IQ. This prediction rapidly increased between ages seven and 16, a period when he says genetics 'really start to take hold.' Although the genes we inherit significantly contribute to our IQ, Dr. Gustavson wants parents to know that heritability doesn't mean 'we can't change who we're going to become.' There are always ways to intervene and learn new skills. The study emphasizes that early environment matters, but it doesn't specify how parents can best nurture cognitive growth. To bridge that gap, we spoke with Sara Douglas, PsyD, Ed.M, a psychologist specializing in neuropsychological evaluations, and pediatrician Heather Gosnell, MD, to offer helpful suggestions. IQ is often viewed as a singular number, but Dr. Douglas says it's essential to look at IQ as one's capacity 'within multiple traits and features.' Here are some simple strategies for holistically nurturing cognitive development in young kids. Viewed this way, a stimulating environment can provide exposure that enhances these traits. Dr. Douglas suggests allowing an infant 'to spend time feeling different textures, seeing different patterns, hearing different notes, [and] interacting with different people.' She adds it's a good idea to 'provide different opportunities for novel experiences. If possible, provide different experiences in the different weeks of development, so young kids have the opportunity both to learn the first [skill], and expand their interest to the next.' Parent-child interaction is also key, says Dr. Gosnell, because 'simple routines like reading, talking, and playing have a powerful impact on brain development and set the foundation for learning.' She recommends reading twenty minutes a day to your infant and continuing this routine through childhood as it supports at-home brain development. You can also narrate your day to help build language skills. And if possible, avoid screen time before 18 months. Once introduced, she says to choose quality programming, watch together, and limit screen time to one hour a day. Remember that this study does not indicate that intelligence is a binary—it's not the case that either they show signs of intelligence early on and will grow upto intelligent, or they don't, and they won't. Intelligence can develop over time, starting with parents who use some of the strategies outlined above. And it doesn't help to stress out over these milestones that will vary from child to child anyway. 'Don't worry if your baby isn't 'advanced' in every area or if they miss one milestone, as uneven development is completely typical,' says Dr. Gosnell. Late talking and short attention spans are also not a cause for concern. 'Most late talkers catch up by age 4 to 7, especially when they understand well, are developing normally in other areas, and receive speech therapy if needed,' Gosnell states. 'Toddlers naturally have very brief focus periods, which is normal and, on their own, don't predict future attention problems.'That said, if you're worried about developmental delays, early intervention will give your child the best chance to reach their full potential. Dr. Gosnell advises talking with your pediatrician if your child isn't 'picking up new skills or seems to be losing abilities they once had.'And remember—IQ and intelligence isn't everything, and definitely does not indicate that your child will be a good person or a productive member of society. 'There are personality traits (like kindness, empathy, genuineness, being a good listener),' says Dr. Douglas, 'that are not factored into intelligence testing that are, in many regards, more important than cognitive traits that are measured.' Read the original article on Parents
Yahoo
an hour ago
- Yahoo
Dr. Aubrey de Grey Brings Cutting-Edge Science to RAADfest 2025: LEV Foundation Partners with Coalition for Radical Life Extension
Renowned biogerontologist Dr. Aubrey de Grey to curate specialized scientific programming at world's leading longevity conference, combining breakthrough research with practical applications. "RAADfest is the leading longevity conference for a general audience. I'll be bringing the same high calibre of science I always do. The event promises to be momentous." --- Dr. Aubrey de Grey, President of the LEV Foundation LAS VEGAS, July 3, 2025 /PRNewswire/ -- Dr. Aubrey de Grey, a biomedical gerontologist who received his BA in computer science and Ph.D. in biology from the University of Cambridge, will headline RAADfest 2025 in a collaboration between the LEV Foundation and the Coalition for Radical Life Extension. Taking place July 10-13, 2025, at the Red Rock Casino Resort and Spa in Las Vegas, this partnership marks the first time Dr. de Grey will curate scientific programming for RAADfest alongside the event's established offerings. Dr. de Grey, founder of the SENS (Strategies for Engineered Negligible Senescence) research framework, brings over two decades of work in damage repair approaches to aging. His LEV Foundation recently completed studies involving 1,000 middle-aged mice, extending their lives by four months through combination therapies. This research represents progress toward what he terms "longevity escape velocity" in humans. His approach to working across organizations like the Healthspan Action Coalition and Alliance for Longevity Initiatives reflects his collaborative approach to advancing the longevity field. "This is not just an event; it's a movement," said James Strole, Director of the Coalition for Radical Life Extension. "By joining forces with the LEV Foundation and incorporating the visionary work of Dr. Aubrey de Grey, we are taking a historic step forward in the fight against aging." The enhanced 2025 program will feature Dr. de Grey's signature approach to presenting complex scientific concepts alongside RAADfest's traditional focus on practical applications and clinical protocols. Attendees will gain access to cutting-edge research on cellular regeneration, mitochondrial repair, senescent cell elimination, and combination therapy approaches that form the backbone of modern rejuvenation science. The event's established non-commercial platform ensures that Dr. de Grey's scientific presentations remain focused on research advancement rather than product promotion. Dr. de Grey's participation extends beyond individual presentations to encompass strategic programming that reflects his broader vision for accelerating the entire longevity field. His collaborative approach—supporting credible radical efforts across diverse organizations rather than building competing institutions—will be evident throughout the expanded scientific track designed to serve both practicing clinicians and PhD-level researchers. The 2025 program will include specialized sessions on Dr. de Grey's seven-category SENS framework, updates from the LEV Foundation's robust mouse rejuvenation studies, and strategic discussions about achieving the critical breakthroughs needed to trigger widespread acceptance of radical life extension research. Interactive panels will explore how damage repair approaches translate from laboratory settings to clinical applications, addressing the practical concerns of healthcare providers and individual longevity advocates. Registration is now open for RAADfest 2025. Complete event details, speaker announcements, and registration information are available at About Dr. Aubrey de Grey Dr. Aubrey de Grey is a biomedical gerontologist, President and Chief Science Officer of the LEV Foundation. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His SENS research framework identifies seven categories of aging damage and corresponding repair strategies. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He has worked with organizations across the longevity field including the Healthspan Action Coalition, Alliance for Longevity Initiatives, and Afro Longevity. About the LEV Foundation The LEV Foundation (Longevity Escape Velocity Foundation) is a nonprofit organization founded by Dr. Aubrey de Grey to accelerate the development and deployment of rejuvenation biotechnology. The Foundation focuses on damage repair approaches to aging and conducting combination therapy studies that demonstrate significant life extension in laboratory settings. LEV Foundation's robust mouse rejuvenation studies represent the cutting edge of longevity research, with recent work achieving meaningful life extension in middle-aged mice through coordinated therapeutic interventions. Learn more: About the Coalition for Radical Life Extension The Coalition for Radical Life Extension is a nonprofit organization dedicated to educating, uniting, and activating people who support radical life extension and super longevity. Founded on principles of unbiased education and community building, the Coalition is best known for producing RAADfest, the world's largest global event dedicated to the science, advocacy, and practical application of human life extension technologies. Learn more: About RAADfest RAADfest (Revolution Against Aging and Death) is the world's most comprehensive event focused on the science and advocacy of human life extension. Celebrating its 10th anniversary in 2025, RAADfest has established itself as the premier destination for cutting-edge longevity research, clinical protocols, and community engagement. The event's unique blend of scientific rigor, practical application, and celebration of life empowers attendees with actionable strategies for extending healthspan and lifespan. RAADfest's non-commercial platform ensures transparent, research-based education without product promotion conflicts. View original content to download multimedia: SOURCE LEV Foundation Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Oppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial Progress
Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. Oppenheimer analysts maintained their $75 price target for Revolution Medicines, Inc. (NASDAQ:RVMD) and reaffirmed their Outperform rating on June 3. Updates from competing KRAS initiatives that were given at this year's ASCO meeting coincide with the reaffirmation. The Oppenheimer analysts pointed out that smaller datasets would provide difficulties for Revolution's rivals in the G12Di arena for pancreatic ductal adenocarcinoma (PDAC). That said, Revolution's Phase 3 trials in second-line and beyond are currently recruiting for PDAC and non-small cell lung cancer (NSCLC. With the initiation of registrational trials in the adjuvant context and first-line metastatic PDAC, focus is now turning to front-line prospects. Potential pipeline updates that could further inform Revolution's development plan are anticipated by the analysts for the second half of the year. Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical-stage biotech company that develops cancer medications that target RAS, a major category of genetic abnormalities that are frequently present in difficult-to-treat cancers. While we acknowledge the potential of RVMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None.
